Cutting-Edge Strategies for HR+/HER2- Breast Cancer: What’s New Worldwide?
HR+/HER2- Breast Cancer: Unveiling the Worldwide Advances and Strategies Introduction Hormone Receptor Positive (HR+)/HER2-Negative (HER2-) breast cancer, a prevalent subtype of breast cancer, continues to be a focal point in oncology research and treatment. This subtype, characterized by the presence of hormone receptors but lack of HER2 overexpression, presents unique challenges and opportunities in the…